Page last updated: 2024-08-26

carbidopa, levodopa drug combination and Spastic Paraplegia, Hereditary

carbidopa, levodopa drug combination has been researched along with Spastic Paraplegia, Hereditary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berg, J; Crooks, K; Evans, J; Fan, Z; Felix, AC; Greenwood, R; Roche, M; Shiloh-Malawsky, Y; Tennison, M; Weck, K; Wilhelmsen, K1

Other Studies

1 other study(ies) available for carbidopa, levodopa drug combination and Spastic Paraplegia, Hereditary

ArticleYear
GCH1 heterozygous mutation identified by whole-exome sequencing as a treatable condition in a patient presenting with progressive spastic paraplegia.
    Journal of neurology, 2014, Volume: 261, Issue:3

    Topics: Adult; Carbidopa; Codon, Nonsense; Dopamine Agonists; Drug Combinations; Dystonic Disorders; Exome; Female; GTP Cyclohydrolase; Heterozygote; Humans; Levodopa; Phenotype; Sequence Analysis, DNA; Spastic Paraplegia, Hereditary; Treatment Outcome

2014